ペプチドベース感染治療薬の世界市場：市場規模・現状・予測

• 英文タイトル：Global Peptide Based Infection Therapeutics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST03972 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、ペプチドベース感染治療薬の世界市場について調査・分析し、ペプチドベース感染治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（テラプレビル、ソフォスブビル、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のペプチドベース感染治療薬市場動向 ・主要企業別マーケットシェア ・ペプチドベース感染治療薬の種類別市場規模2014-2019 （テラプレビル、ソフォスブビル、その他） ・ペプチドベース感染治療薬の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・ペプチドベース感染治療薬の北米市場：主要企業・種類別/用途別市場規模 ・ペプチドベース感染治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ペプチドベース感染治療薬の中国市場：主要企業・種類別/用途別市場規模 ・ペプチドベース感染治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・ペプチドベース感染治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・ペプチドベース感染治療薬のインド市場：主要企業・種類別/用途別市場規模 ・ペプチドベース感染治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Gilead Sciences、Johnson & Johnson (Janssen)、Vertex Pharmaceuticals、Mitsubishi Tanabe Pharma、Medivir） ・ペプチドベース感染治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective.Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market.
In 2018, the global Peptide Based Infection Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Peptide Based Infection Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide Based Infection Therapeutics development in United States, Europe and China.

The key players covered in this study
Gilead Sciences
Johnson & Johnson (Janssen)
Vertex Pharmaceuticals
Mitsubishi Tanabe Pharma
Medivir
…

Market segment by Type, the product can be split into
Telaprevir
Sofosbuvir
Others

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Peptide Based Infection Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Peptide Based Infection Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Peptide Based Infection Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Peptide Based Infection Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Telaprevir
1.4.3 Sofosbuvir
1.4.4 Others
1.5 Market by Application
1.5.1 Global Peptide Based Infection Therapeutics Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Peptide Based Infection Therapeutics Market Size
2.2 Peptide Based Infection Therapeutics Growth Trends by Regions
2.2.1 Peptide Based Infection Therapeutics Market Size by Regions (2014-2025)
2.2.2 Peptide Based Infection Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Peptide Based Infection Therapeutics Market Size by Manufacturers
3.1.1 Global Peptide Based Infection Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Peptide Based Infection Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Peptide Based Infection Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Peptide Based Infection Therapeutics Key Players Head office and Area Served
3.3 Key Players Peptide Based Infection Therapeutics Product/Solution/Service
3.4 Date of Enter into Peptide Based Infection Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Peptide Based Infection Therapeutics Market Size by Type (2014-2019)
4.2 Global Peptide Based Infection Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Peptide Based Infection Therapeutics Market Size (2014-2019)
5.2 Peptide Based Infection Therapeutics Key Players in United States
5.3 United States Peptide Based Infection Therapeutics Market Size by Type
5.4 United States Peptide Based Infection Therapeutics Market Size by Application

6 Europe
6.1 Europe Peptide Based Infection Therapeutics Market Size (2014-2019)
6.2 Peptide Based Infection Therapeutics Key Players in Europe
6.3 Europe Peptide Based Infection Therapeutics Market Size by Type
6.4 Europe Peptide Based Infection Therapeutics Market Size by Application

7 China
7.1 China Peptide Based Infection Therapeutics Market Size (2014-2019)
7.2 Peptide Based Infection Therapeutics Key Players in China
7.3 China Peptide Based Infection Therapeutics Market Size by Type
7.4 China Peptide Based Infection Therapeutics Market Size by Application

8 Japan
8.1 Japan Peptide Based Infection Therapeutics Market Size (2014-2019)
8.2 Peptide Based Infection Therapeutics Key Players in Japan
8.3 Japan Peptide Based Infection Therapeutics Market Size by Type
8.4 Japan Peptide Based Infection Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Peptide Based Infection Therapeutics Market Size (2014-2019)
9.2 Peptide Based Infection Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Peptide Based Infection Therapeutics Market Size by Type
9.4 Southeast Asia Peptide Based Infection Therapeutics Market Size by Application

10 India
10.1 India Peptide Based Infection Therapeutics Market Size (2014-2019)
10.2 Peptide Based Infection Therapeutics Key Players in India
10.3 India Peptide Based Infection Therapeutics Market Size by Type
10.4 India Peptide Based Infection Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Peptide Based Infection Therapeutics Market Size (2014-2019)
11.2 Peptide Based Infection Therapeutics Key Players in Central & South America
11.3 Central & South America Peptide Based Infection Therapeutics Market Size by Type
11.4 Central & South America Peptide Based Infection Therapeutics Market Size by Application

12 International Players Profiles
12.1 Gilead Sciences
12.1.1 Gilead Sciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Peptide Based Infection Therapeutics Introduction
12.1.4 Gilead Sciences Revenue in Peptide Based Infection Therapeutics Business (2014-2019)
12.1.5 Gilead Sciences Recent Development
12.2 Johnson & Johnson (Janssen)
12.2.1 Johnson & Johnson (Janssen) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Peptide Based Infection Therapeutics Introduction
12.2.4 Johnson & Johnson (Janssen) Revenue in Peptide Based Infection Therapeutics Business (2014-2019)
12.2.5 Johnson & Johnson (Janssen) Recent Development
12.3 Vertex Pharmaceuticals
12.3.1 Vertex Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Peptide Based Infection Therapeutics Introduction
12.3.4 Vertex Pharmaceuticals Revenue in Peptide Based Infection Therapeutics Business (2014-2019)
12.3.5 Vertex Pharmaceuticals Recent Development
12.4 Mitsubishi Tanabe Pharma
12.4.1 Mitsubishi Tanabe Pharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Peptide Based Infection Therapeutics Introduction
12.4.4 Mitsubishi Tanabe Pharma Revenue in Peptide Based Infection Therapeutics Business (2014-2019)
12.4.5 Mitsubishi Tanabe Pharma Recent Development
12.5 Medivir
12.5.1 Medivir Company Details
12.5.2 Company Description and Business Overview
12.5.3 Peptide Based Infection Therapeutics Introduction
12.5.4 Medivir Revenue in Peptide Based Infection Therapeutics Business (2014-2019)
12.5.5 Medivir Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Peptide Based Infection Therapeutics Key Market Segments
Table Key Players Peptide Based Infection Therapeutics Covered
Table Global Peptide Based Infection Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Peptide Based Infection Therapeutics Market Size Market Share by Type 2014-2025
Figure Telaprevir Figures
Table Key Players of Telaprevir
Figure Sofosbuvir Figures
Table Key Players of Sofosbuvir
Figure Others Figures
Table Key Players of Others
Table Global Peptide Based Infection Therapeutics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Peptide Based Infection Therapeutics Report Years Considered
Table Global Peptide Based Infection Therapeutics Market Size 2014-2025 (Million US$)
Figure Global Peptide Based Infection Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Peptide Based Infection Therapeutics Market Size by Regions 2014-2025 (Million US$)
Table Global Peptide Based Infection Therapeutics Market Size by Regions 2014-2019 (Million US$)
Table Global Peptide Based Infection Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Infection Therapeutics Market Share by Regions 2014-2019
Figure Global Peptide Based Infection Therapeutics Market Share by Regions 2019
Table Market Top Trends
Table Global Peptide Based Infection Therapeutics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Peptide Based Infection Therapeutics Market Share by Manufacturers (2014-2019)
Figure Global Peptide Based Infection Therapeutics Market Share by Manufacturers in 2018
Table Global Peptide Based Infection Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Peptide Based Infection Therapeutics Product/Solution/Service
Table Date of Enter into Peptide Based Infection Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Peptide Based Infection Therapeutics Market Size Share by Type (2014-2019)
Figure Global Peptide Based Infection Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Peptide Based Infection Therapeutics Market Size Share by Application (2014-2019)
Figure Global Peptide Based Infection Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Peptide Based Infection Therapeutics Revenue Market Share by Application in 2018
Figure United States Peptide Based Infection Therapeutics Market Size 2014-2019 (Million US$)
Table United States Key Players Peptide Based Infection Therapeutics Revenue (2018-2019) (Million US$)
Table United States Key Players Peptide Based Infection Therapeutics Market Share (2018-2019)
Table United States Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table United States Peptide Based Infection Therapeutics Market Share by Type (2014-2019)
Table United States Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table United States Peptide Based Infection Therapeutics Market Share by Application (2014-2019)
Figure Europe Peptide Based Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Peptide Based Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Peptide Based Infection Therapeutics Market Share (2018-2019)
Table Europe Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Europe Peptide Based Infection Therapeutics Market Share by Type (2014-2019)
Table Europe Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Europe Peptide Based Infection Therapeutics Market Share by Application (2014-2019)
Figure China Peptide Based Infection Therapeutics Market Size 2014-2019 (Million US$)
Table China Key Players Peptide Based Infection Therapeutics Revenue (2018-2019) (Million US$)
Table China Key Players Peptide Based Infection Therapeutics Market Share (2018-2019)
Table China Peptide Based Infection Therapeutics Market Size by Type (2014-20189) (Million US$)
Table China Peptide Based Infection Therapeutics Market Share by Type (2014-2019)
Table China Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table China Peptide Based Infection Therapeutics Market Share by Application (2014-2019)
Figure Japan Peptide Based Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Japan Key Players Peptide Based Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Japan Key Players Peptide Based Infection Therapeutics Market Share (2018-2019)
Table Japan Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Japan Peptide Based Infection Therapeutics Market Share by Type (2014-2019)
Table Japan Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Japan Peptide Based Infection Therapeutics Market Share by Application (2014-2019)
Figure Southeast Asia Peptide Based Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Peptide Based Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Peptide Based Infection Therapeutics Market Share (2018-2019)
Table Southeast Asia Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Infection Therapeutics Market Share by Type (2014-2019)
Table Southeast Asia Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Peptide Based Infection Therapeutics Market Share by Application (2014-2019)
Figure India Peptide Based Infection Therapeutics Market Size 2014-2019 (Million US$)
Table India Key Players Peptide Based Infection Therapeutics Revenue (2018-2019) (Million US$)
Table India Key Players Peptide Based Infection Therapeutics Market Share (2018-2019)
Table India Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table India Peptide Based Infection Therapeutics Market Share by Type (2014-2019)
Table India Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table India Peptide Based Infection Therapeutics Market Share by Application (2014-2019)
Figure Central & South America Peptide Based Infection Therapeutics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Peptide Based Infection Therapeutics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Peptide Based Infection Therapeutics Market Share (2018-2019)
Table Central & South America Peptide Based Infection Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Peptide Based Infection Therapeutics Market Share by Type (2014-2019)
Table Central & South America Peptide Based Infection Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Peptide Based Infection Therapeutics Market Share by Application (2014-2019)
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Peptide Based Infection Therapeutics Business (2014-2019) (Million US$)
Figure Gilead Sciences Revenue Growth Rate in Peptide Based Infection Therapeutics Business (2014-2019)
Table Gilead Sciences Recent Development
Table Johnson & Johnson (Janssen) Company Details
Table Johnson & Johnson (Janssen) Revenue in Peptide Based Infection Therapeutics Business (2014-2019)(Million US$)
Figure Johnson & Johnson (Janssen) Revenue Growth Rate in Peptide Based Infection Therapeutics Business (2014-2019)
Table Johnson & Johnson (Janssen) Recent Development
Table Vertex Pharmaceuticals Company Details
Table Vertex Pharmaceuticals Revenue in Peptide Based Infection Therapeutics Business (2014-2019)(Million US$)
Figure Vertex Pharmaceuticals Revenue Growth Rate in Peptide Based Infection Therapeutics Business (2014-2019)
Table Vertex Pharmaceuticals Recent Development
Table Mitsubishi Tanabe Pharma Company Details
Table Mitsubishi Tanabe Pharma Revenue in Peptide Based Infection Therapeutics Business (2014-2019)(Million US$)
Figure Mitsubishi Tanabe Pharma Revenue Growth Rate in Peptide Based Infection Therapeutics Business (2014-2019)
Table Mitsubishi Tanabe Pharma Recent Development
Table Medivir Company Details
Table Medivir Revenue in Peptide Based Infection Therapeutics Business (2014-2019)(Million US$)
Figure Medivir Revenue Growth Rate in Peptide Based Infection Therapeutics Business (2014-2019)
Table Medivir Recent Development
Table Global Peptide Based Infection Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Peptide Based Infection Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Peptide Based Infection Therapeutics Market Size Share by Regions in 2025
Figure United States Peptide Based Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Peptide Based Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure China Peptide Based Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Peptide Based Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Peptide Based Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure India Peptide Based Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Peptide Based Infection Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Peptide Based Infection Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Peptide Based Infection Therapeutics Market Size by Product (2019-2025)
Figure Global Peptide Based Infection Therapeutics Market Size by Product in 2025
Table Global Peptide Based Infection Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Peptide Based Infection Therapeutics Market Size by Application (2019-2025)
Figure Global Peptide Based Infection Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---